β-Actin-derived peptides isolated from acidic extract of rat spleen suppress tumor cell growth

Journal of Peptide Science

Volumn 14, Issue 7, 2008, Pages 811-818

  Blishchenko, Elena Y ^a   Sazonova, Olga V ^a   Yatskin, Oleg N ^a   Kalinina, Olga A ^a   Tolmazova, Anna G ^a   Philippova, Marina M ^a   Karelin, Andrei A ^a   Ivanov, Vadim T ^a  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

Author keywords

Antiproliferative effect; Cytotoxicity; Protein fragment; Proteolysis; Tumor cells

Indexed keywords

BETA ACTIN; BETA ACTIN DERIVATIVE; BETA ACTIN[67-89]; BETA ACTIN[69-76]; BETA ACTIN[69-77]; BETA ACTIN[69-89]; BETA ACTIN[73-89]; BETA ACTIN[75-90]; BETA ACTIN[76-89]; BETA ACTIN[78-86]; BETA ACTIN[78-87]; BETA ACTIN[78-88]; BETA ACTIN[78-89]; BETA ACTIN[78-90]; BETA ACTIN[79-87]; BETA ACTIN[79-89]; BETA ACTIN[79-90]; BETA ACTIN[80-87]; BETA ACTIN[80-88]; BETA ACTIN[80-89]; BETA ACTIN[83-90]; EPIRUBICIN; PROTEIN DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CELL STRAIN L 929; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENCY; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ISOLATION; RAT; SPLEEN;

ACIDS; ACTINS; AMINO ACID SEQUENCE; ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; MICE; MOLECULAR SEQUENCE DATA; NEOPLASMS; PEPTIDES; RATS; RATS, WISTAR; SPLEEN; TISSUE EXTRACTS;

MURINAE; RATTUS;

EID: 48249128376     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1008     Document Type: Article

References (45)

1. Stossel TP. Contractile proteins in cell structure and function. Annu. Rev. Med. 1978; 29: 427-457.
2. Van Opstal A, Bijvelt JJ, Margadant C, Boonstra J. Role of signal transduction and actin in G1 phase progression. Adv. Enzyme Regul. 2005; 45: 186-200.
3. Davoodian K, Ritchings BW, Ramphal R, Bubb MR. Gelsolin activates DNase I in vitro and cystic fibrosis sputum. Biochemistry 1997; 36: 9637-9641.
4. Kayalar C, Ord T, Pia Testa M, Zhong LT, Bredesen DE. Cleavage of actin by interleukin 1 β-converting enzyme to reverse Dnase I inhibition. Proc. Natl. Acad. Sci. U.S.A. 1996; 93: 2234-2238.
5. Rao JY, Jin YS, Zheng Q, Cheng J, Tai J, Hemstreet GP III. Alterations of the actin polymerization status as an apoptotic morphological effector in HL-60 cells. J. Cell. Biochem. 1999; 75: 686-697.
6. Gourlay CW, Ayscough KR. The actin cytoskeleton in ageing and apoptosis. FEMS Yeast Res. 2005; 5(12): 1193-1198.
7. Mashima T, Naito M, Tsuruo T. Caspase-mediated cleavage of cytoskeletal actin plays a positive role in the process of morphological apoptosis. Oncogene 1999; 18: 2423-2430.
8. Neradil J, Veselska R, Svoboda A. The role of actin in the apoptotic cell death of P19 embryonal carcinoma cells. Int. J. Oncol. 2005; 27: 1013-1021.
9. Du J, Wang X, Miereles C, Bailey JL, Debigare R, Zheng B, Price SR, Mitch WE. Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions. J. Clin. Invest. 2004; 113: 115-123.
10. Lee WM, Galbraith RM. The extracellular actin-scavenger system and actin toxicity. N. Engl. J. Med. 1992; 326: 1335-1341.
11. Erukhimov JA, Tang ZL, Johnson BA, Donahoe MP, Razzack JA, Gibson KD. Lee WM, Wasserloos KJ, Watkins SA, Pitt BR. Actin-containing sera from patients with adult respiratory distress syndrome are toxic to sheep pulmonary endothelial cells. Am. J. Respir. Crit. Care Med. 2000; 162: 288-294.
12. Yatskin ON, Philippova MM, Blishchenko EY, Karelin AA, Ivanov VT. LVV- and VV-hemorphins: comparative levels in rat tissues. FEBS Lett. 1998; 428: 286-290.
13. Karelin AA, Philippova MM, Yatskin ON, Kalinina OA, Nazimov IV, Elishchenko EY, Ivanov VT. Peptides comprising the bulk of rat brain extracts: isolation, amino acid sequences and biological activity. J. Pept. Sci. 2000; 6: 345-354.
14. Karelin AA, Philippova MM, Karelina EV, Strizhkov BN, Grishina GA. Nazimov IV, Ivanov VT. Peptides from bovine brain: structure and biological role. J. Pept. Sci. 1998; 4: 211-225.
15. Ivanov VT, Yatskin ON. Peptidomics: a logical sequel to proteomics. Expert Rev. Proteomics 2005; 2: 463-473.
16. Philippova MM, Yatskin ON, Elishchenko EY, Khachin DP, Sazonova OV, Nazimov IV, Karelin AA, Ivanov VT, Rasstrigin NA, Pivnik AV. Primary culture of human erythrocytes specifically releases fragments of self proteins. Bioorg. Khim. 2008; 34, (in press).
17. Blishchenko EY, Sazonova OV, Surovoy AY, Khaidukov SV, Sheikine Y, Sokolov D, Freidlin IS, Philippova MM, Vass AA, Karelin AA, Ivanov VT. Antiproliferative action of valorphin in cell cultures. J. Pept. Sci. 2002; 8: 438-452.
18. Chlopkiewicz B. Evaluation of adriamycin induced DNA damage and repair in human and animal cells. Acta Pol. Pharm. 2002; 59: 115-120.
19. Sugarman BJ, Aggarwal BB, Hass PE, Figari IS, Palladino MA Jr, Shepard HM. Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. Science 1985; 230: 943-945.
20. Sazonova OV, Yatskin ON, Khachin DP, Blishchenko EY, Karelin AA, Ivanov VT. Isolation of peptides from rat tissues: peptidomics vs. degradomics. In Peptides, Escher E, Lubell WD, Del Valle S. (eds.), 2008; (in press).
21. Che FY, Lim J, Pan H, Biswas R, Fricker LD. Quantitative neuropeptidomics of microwave-irradiated mouse brain and pituitary. Mol. Cell. Proteomics 2005; 4: 1391-1405.
22. Ivanov VT, Karelin AA, Yatskin ON. Generation of peptides by human erythrocytes: facts and artifacts. Biopolymers 2005; 80: 332-346.
23. Ueki N, Someya K, Matsuo Y, Wakamatsu K, Mukai H. Cryptides: functional cryptic peptides hidden in protein structures. Biopolymers 2007; 88: 190-198.
24. Subramaniyam D, Glader P, von Wachenfeldt K, Burneckiene J, Stevens T, Janciauskiene S. C-36 peptide, a degradation product of alpha1-antitrypsin, modulates human monocyte activation through LPS signaling pathways. Int. J. Biochem. Cell Biol. 2006; 38: 563-575.
25. Meisel H. Biochemical properties of peptides encrypted in bovine milk proteins. Curr. Med. Chem. 2005; 12: 1905-1919.
26. Nakagomi K, Ebisu H, Sadakane Y, Fujii N, Akizawa T, Tanimura T. Properties and human origin of two angiotensin-I-converting enzyme inhibitory peptides isolated from a tryptic hydrolysate of human serum albumin. Biol. Pharm. Bull. 2000: 23: 879-883.
27. Nakagomi K, Fujimura A, Ebisu H, Sakai T, Sadakane Y, Fujii N, Tanimura T. Acein-1, a novel angiotensin-I-converting enzyme inhibitory peptide isolated from tryptic hydrolysate of human plasma. FEBS Lett. 1998; 438: 255-257.
28. Mito K, Fujii M, Kuwahara M, Matsumura N, Shimizu T, Sugano S, Karaki H. Antihypertensive effect of angiotensin I-converting enzyme inhibitory peptides derived from hemoglobin. Eur. J. Pharmacol. 1996; 304: 93-98.
29. Yu Y, Hu J, Miyaguchi Y, Bai X, Du Y, Lin B. Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides derived from porcine hemoglobin. Peptides 2006; 27: 2950-2956.
30. Zhao Q, Piot JM. Investigation of inhibition angiotensin-converting enzyme (ACE) activity and opioid activity of two hemorphins, LVV-hemorphin-5 and VV-hemorphin-5, isolated from a defined peptic hydrolysate of bovine hemoglobin. Neuropeptides 1997; 31: 147-153.
31. Yokoyama K, Chiba H, Yoshikawa M. Peptides inhibitors for angiotensin I-converting enzyme from thermolysin digest of dried bonito. Biosci. Biotechnol. Biochem. 1992; 56: 1541-1545.
32. Saiga A, Tanabe S, Nishimura T. Antioxidant activity of peptides obtained from porcine myofibrillar proteins by protease treatment. J. Agric. Food Chem. 2003; 51: 3661-3667.
33. Togashi S, Takahashi N, Iwama M, Watanabe S, Tamagawa K, Fukui T. Antioxidative collagen-derived peptides in human-placenta extract. Placenta 2002; 23: 497-502.
34. Mendis E, Rajapakse N, Byun HG, Kim SK. Investigation of jumbo squid (Dosidicus gigas) skin gelatin peptides for their in vitro antioxidant effects. Life Sci. 2005; 77: 2166-2178.
35. Roy MK, Kuwabara Y, Hara K, Watanabe Y, Tamai Y. Peptides from the N-terminal end of bovine lactoferrin induce apoptosis in human leukemic (HL-60) cells. J. Dairy Sci. 2002; 85: 2065-2074.
36. Nyberg F, Sanderson K, Glamsta EV. The hemorphins: a new class of opioid peptides derived from the blood protein hemoglobin. Biopolymers 1997; 43: 147-156.
37. Nakagomi K, Fujimura A, Maeda H, Sadakane Y, Fujii N, Akizawa T, Tanimura T, Hatanaka Y. Isolation of novel peptides, cabin-1, -2, -3, and -4, that inhibit cathepsin B from a thermolysin digest of human plasma. Biol. Pharm. Bull. 2002; 25: 564-568.
38. Kamiya S, Kawaguchi T, Hasebe S, Kamiya N, Saito Y, Miura S, Wada S, Yajima H, Katayama T, Fukai F. A fibronectin fragment induces tumor necrosis factor production of rat basophilic leukemia cells. Biochim. Biophys. Acta 2004; 1675: 87-94.
39. Zhao Q, Sannier F, Garreau I, Guillochon D, Piot JM. Inhibition and inhibition kinetics of angiotensin converting enzyme activity by hemorphins, isolated from a peptic bovine hemoglobin hydrolysate. Biochem. Biophys. Res. Commun. 1994; 204: 216-223.
40. Cohen M, Fruitier-Arnaudin I, Piot JM. Hemorphins: substrates and/or inhibitors of dipeptidyl peptidase IV. Hemorphins N-terminus sequence influence on the interaction between hemorphins and DPPIV. Biochimie 2004; 86: 31-37.
41. Lee J, Mustafa T, McDowall SG, Mendelsohn FA, Brennan M, Lew RA, Albiston AL, Chai SY. Structure-activity study of LVV-hemorphin-7: angiotensin AT4 receptor ligand and inhibitor of insulin-regulated aminopeptidase. J. Pharmacol. Exp. Ther. 2003; 305: 205-211.
42. Blishchenko EY, Sazonova OV, Kalinina OA, Yatskin ON, Philippova MM, Surovoy AY, Karelin AA, Ivanov VT. Family of hemorphins: co-relations between amino acid sequences and effects in cell cultures. Peptides 2002; 23: 903-910.
43. Blishchenko EY, Sazonova OV, Surovoy AY, Khaidukov SV, Sheikine Y, Sokolov DI, Freidlin IS, Philippova MM, Vass AA, Karelin AA, Ivanov VT. Antiproliferative action of valorphin in cell cultures. J. Pept. Sci. 2002; 8: 438-452.
44. Liepke C, Baxmann S, Heine C, Breithaupt N, Standker L, Forssmann WG. Human hemoglobin-derived peptides exhibit antimicrobial activity: a class of host defense peptides. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2003; 791: 345-356.
45. Wang Y, Griffiths WJ, Jornvall H, Agerberth B, Johansson J. Antibacterial peptides in stimulated human granulocytes: characterization of ubiquitinated histone H1A. Eur. J. Biochem. 2002; 269: 512-518.